Prevention of lung infections associated with human immunodeficiency virus infection

scientific article

Prevention of lung infections associated with human immunodeficiency virus infection is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1136/THX.44.12.1038
P932PMC publication ID1020882
P698PubMed publication ID2575801
P5875ResearchGate publication ID20579973

P2093author name stringHopewell PC
P2860cites workThe efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialQ29620785
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialQ29620805
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.Q33452645
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohortQ36895424
Pneumococcal polysaccharide vaccineQ38219799
Bacterial pneumonia in patients with human immunodeficiency virus infectionQ38229000
Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and preventionQ38663570
Tuberculosis and human immunodeficiency virus infectionQ38663578
Controlled chemoprophylaxis trials in tuberculosis. A general reviewQ39002300
Successful Chemoprophylaxis forPneumocystis cariniiPneumonitisQ41342669
B-cell immunodeficiency in acquired immune deficiency syndromeQ41431679
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS.Q44651113
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York CityQ45055408
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infectionQ45839569
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infectionQ45845673
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survivalQ46306051
Aerosolized pentamidine as second line therapy in patients with AIDS and Pneumocystis carinii pneumonia.Q54111182
Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual menQ58737476
Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDSQ68090731
Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndromeQ68804903
The combined toxicity of azidothymidine and antimycobacterial agents. A retrospective studyQ69595405
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)1038-1044
P577publication date1989-12-01
P1433published inThoraxQ7796158
P1476titlePrevention of lung infections associated with human immunodeficiency virus infection
P478volume44

Reverse relations

cites work (P2860)
Q68271469A comparison of several agents with two delivery systems for the prevention of airway narrowing induced by nebulised pentamidine isethionate
Q38546468Animal models of polymicrobial pneumonia
Q36726943Medical management of AIDS patients. Bacterial and fungal infections.
Q33935513Pneumococcal vaccine and HIV infection: report of a vaccine failure and reappraisal of its value in clinical practice
Q36380969Pneumocystis carinii pneumonia after 40 years
Q36235474Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications
Q35246794The impact of the HIV epidemic on tuberculosis control programmes in developing countries
Q36688887Tuberculosis and HIV co-infection: a practical therapeutic approach

Search more.